{"id":"levofloxacin-500","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"7%","effect":"Diarrhea"},{"rate":"5%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL33","moleculeType":"Small molecule","molecularWeight":"361.37"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"DNA gyrase is a type II topoisomerase that introduces negative supercoils into DNA, while topoisomerase IV decatenates DNA, both essential for bacterial survival and proliferation. By inhibiting these enzymes, levofloxacin effectively kills bacteria.","oneSentence":"Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and repair.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:42:27.672Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Complicated urinary tract infections"}]},"trialDetails":[{"nctId":"NCT07487142","phase":"PHASE3","title":"Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding\"","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-06-10","conditions":"H Pylori Infection","enrollment":121},{"nctId":"NCT07454772","phase":"PHASE1, PHASE2","title":"Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis","status":"NOT_YET_RECRUITING","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2026-03-15","conditions":"Granulomatous Mastitis","enrollment":72},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT02701608","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":162},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT07320534","phase":"PHASE4","title":"Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase","status":"NOT_YET_RECRUITING","sponsor":"Gadjah Mada University","startDate":"2026-01-01","conditions":"Neutropenic Fever, Acute Lymphoblastic Leukemia","enrollment":124},{"nctId":"NCT03594149","phase":"PHASE3","title":"Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients","status":"COMPLETED","sponsor":"Centre Henri Becquerel","startDate":"2018-07-18","conditions":"Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":60},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT03850379","phase":"PHASE2","title":"Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2018-03-14","conditions":"Prophylaxis, Stem Cell Transplant Complications","enrollment":308},{"nctId":"NCT05332444","phase":"PHASE4","title":"Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-04-11","conditions":"Helicobacter Pylori Infection","enrollment":450},{"nctId":"NCT03935828","phase":"PHASE2","title":"Effect of Topical Sinonasal Antibiotics","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2019-06","conditions":"Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect","enrollment":""},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT01710488","phase":"PHASE4","title":"Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD","status":"COMPLETED","sponsor":"Fadoi Foundation, Italy","startDate":"2009-05","conditions":"COPD Exacerbation","enrollment":258},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT06200779","phase":"PHASE4","title":"Tailored Vs. Empirical Helicobacter Pylori Infection Treatment","status":"NOT_YET_RECRUITING","sponsor":"Manuel Coelho da Rocha","startDate":"2025-09","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT06684626","phase":"PHASE3","title":"The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment","status":"COMPLETED","sponsor":"Federico II University","startDate":"2024-03-01","conditions":"Prostate Inflammation, Prostate Disease, Chronic Bacterial Prostatitis","enrollment":60},{"nctId":"NCT03867136","phase":"PHASE4","title":"Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2020-06-01","conditions":"Multidrug Resistant Tuberculosis","enrollment":354},{"nctId":"NCT06017479","phase":"PHASE1, PHASE2","title":"Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-12-30","conditions":"Urological System Complication of Procedure, Urinary Tract Infections","enrollment":126},{"nctId":"NCT06414707","phase":"PHASE3","title":"Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-10-12","conditions":"Helicobacter Pylori Infection","enrollment":320},{"nctId":"NCT06275204","phase":"","title":"H. Pylori Screen-and-treat Study in a Population of Young Adults","status":"RECRUITING","sponsor":"University of Latvia","startDate":"2024-03-04","conditions":"Gastric Cancer, H Pylori Infection, H Pylori Eradication","enrollment":6800},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT05549115","phase":"NA","title":"Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Liaocheng People's Hospital","startDate":"2022-09-20","conditions":"Helicobacter Pylori Infection","enrollment":500},{"nctId":"NCT05219877","phase":"PHASE1, PHASE2","title":"Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-02-04","conditions":"Urinary Tract Infections","enrollment":134},{"nctId":"NCT02547025","phase":"NA","title":"Personalized Treatment for Refractory H Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2012-08-01","conditions":"Helicobacter Pylori Infection","enrollment":126},{"nctId":"NCT03779074","phase":"PHASE3","title":"Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2018-09-03","conditions":"Helicobacter Pylori Infection","enrollment":918},{"nctId":"NCT03779087","phase":"NA","title":"Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Ping-I (William) Hsu, M.D.","startDate":"2018-07-11","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT06101420","phase":"PHASE3","title":"Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Helicobacter Pylori Eradication","enrollment":232},{"nctId":"NCT06065267","phase":"PHASE4","title":"Levofloxacin Concomitant Versus Levofloxacin Sequential","status":"NOT_YET_RECRUITING","sponsor":"Damascus Hospital","startDate":"2024-01-02","conditions":"Helicobacter Pylori Infection","enrollment":150},{"nctId":"NCT06049758","phase":"NA","title":"D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy","status":"NOT_YET_RECRUITING","sponsor":"General Committee of Teaching Hospitals and Institutes, Egypt","startDate":"2024-01-02","conditions":"Blood Loss, Intensive Care, Anastomotic Leakage","enrollment":80},{"nctId":"NCT05863858","phase":"PHASE3","title":"Eradication of H. Pylori Infection With Moxifloxacin","status":"COMPLETED","sponsor":"Iyad Naeem Muhammad, PhD","startDate":"2020-06-01","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to","enrollment":162},{"nctId":"NCT05173493","phase":"","title":"The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure","status":"COMPLETED","sponsor":"Shandong University","startDate":"2021-12-30","conditions":"Helicobacter Pylori Infection","enrollment":670},{"nctId":"NCT03551210","phase":"PHASE3","title":"Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"R-Pharm","startDate":"2016-05-04","conditions":"Pneumonia, Bacterial","enrollment":342},{"nctId":"NCT05728424","phase":"PHASE3","title":"One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2022-09-20","conditions":"Helicobacter Pylori Infection","enrollment":246},{"nctId":"NCT05393505","phase":"PHASE4","title":"Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-10-24","conditions":"Neutropenic Fever","enrollment":344},{"nctId":"NCT05339295","phase":"PHASE1","title":"Bioequivalence Study of Levomerc 500 mg Tablets","status":"COMPLETED","sponsor":"University of Karachi","startDate":"2012-07-11","conditions":"Healthy, Pharmacokintetics","enrollment":24},{"nctId":"NCT03619252","phase":"PHASE4","title":"Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents","status":"COMPLETED","sponsor":"Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology","startDate":"2018-07-01","conditions":"Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia","enrollment":36},{"nctId":"NCT05184491","phase":"PHASE4","title":"Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management","status":"UNKNOWN","sponsor":"National Liver Institute, Egypt","startDate":"2021-10-15","conditions":"Helicobacter Pylori","enrollment":500},{"nctId":"NCT02205112","phase":"PHASE3","title":"A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2014-06","conditions":"Community-acquired Pneumonia","enrollment":598},{"nctId":"NCT02454205","phase":"PHASE2, PHASE3","title":"An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2015-11-12","conditions":"Tuberculosis, Multidrug Resistant Tuberculosis, Extensively-drug Resistant Tuberculosis","enrollment":154},{"nctId":"NCT04488458","phase":"NA","title":"Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections","status":"UNKNOWN","sponsor":"Vastra Gotaland Region","startDate":"2021-08-15","conditions":"Prosthetic Joint Infection, Prosthetic Infection, Hip Prosthesis Infection","enrollment":40},{"nctId":"NCT03201796","phase":"PHASE2","title":"Prulifloxacin in Chronic Bacterial Prostatitis (CBP)","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2016-02-02","conditions":"Chronic Bacterial Prostatitis","enrollment":168},{"nctId":"NCT01988779","phase":"PHASE3","title":"Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2013-10","conditions":"Chronic Rhinosinusitis","enrollment":33},{"nctId":"NCT04584840","phase":"NA","title":"Initial Management of MRONJ Stages I and II, a Clinical Trial With Detection of Salivary Biomarkers","status":"UNKNOWN","sponsor":"Fundació d'investigació Sanitària de les Illes Balears","startDate":"2020-11-01","conditions":"Osteonecrosis of the Jaw, Bisphosphonate Induced, Osteonecrosis of the Jaw, Bisphosphonate Related","enrollment":50},{"nctId":"NCT04107194","phase":"PHASE3","title":"Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.","status":"UNKNOWN","sponsor":"University of Bari","startDate":"2020-01-14","conditions":"Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain","enrollment":362},{"nctId":"NCT03697993","phase":"PHASE4","title":"Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-11-07","conditions":"Urinary Tract Infection","enrollment":62},{"nctId":"NCT04626193","phase":"PHASE4","title":"LOAD VS Levofloxacine Concomitant","status":"UNKNOWN","sponsor":"Damascus Hospital","startDate":"2020-10-31","conditions":"Helicobacter Pylori Infection","enrollment":80},{"nctId":"NCT03236961","phase":"NA","title":"Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Turku University Hospital","startDate":"2017-04-03","conditions":"Acute Appendicitis","enrollment":552},{"nctId":"NCT03257423","phase":"NA","title":"Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2017-04-04","conditions":"Acute Appendicitis","enrollment":200},{"nctId":"NCT03234296","phase":"NA","title":"Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis","status":"ENROLLING_BY_INVITATION","sponsor":"Turku University Hospital","startDate":"2017-08-09","conditions":"Acute Appendicitis","enrollment":147},{"nctId":"NCT02067780","phase":"PHASE3","title":"Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2017-05-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":310},{"nctId":"NCT04558463","phase":"PHASE3","title":"The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-04-16","conditions":"Covid19","enrollment":100},{"nctId":"NCT04348786","phase":"PHASE4","title":"Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori","status":"COMPLETED","sponsor":"Damascus Hospital","startDate":"2019-02-01","conditions":"Helicobacter Pylori Infection","enrollment":78},{"nctId":"NCT04432233","phase":"PHASE4","title":"Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-06-15","conditions":"Helicobacter Pylori Infection, Intravenous Drug Usage","enrollment":60},{"nctId":"NCT04359966","phase":"NA","title":"Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia","status":"UNKNOWN","sponsor":"Slovenian Society for Gastroenterology and Hepatology","startDate":"2020-05-10","conditions":"Helicobacter Pylori Infection, Eradication Treatments","enrollment":560},{"nctId":"NCT04353362","phase":"PHASE4","title":"Alternative Antibiotic Regimen in Periodontitis Treatment","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2017-04-01","conditions":"Amoxicillin, Metronidazole, Ofloxacin","enrollment":74},{"nctId":"NCT03159845","phase":"PHASE2","title":"Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies","status":"COMPLETED","sponsor":"Azienda Ospedaliero, Universitaria Pisana","startDate":"2014-01-01","conditions":"Stem Cell Transplant Complications","enrollment":20},{"nctId":"NCT01951768","phase":"PHASE4","title":"Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2013-09","conditions":"Diabetic Foot Ulcer","enrollment":88},{"nctId":"NCT04090021","phase":"PHASE4","title":"Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.","status":"UNKNOWN","sponsor":"Konstantopoulio-Patission General Hospital of Nea Ionia","startDate":"2019-09-01","conditions":"Helicobacter Pylori Infection","enrollment":304},{"nctId":"NCT02978157","phase":"NA","title":"Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2015-02","conditions":"Helicobacter Pylori Infection","enrollment":102},{"nctId":"NCT02547012","phase":"NA","title":"Comparison of Two Rescue Therapies for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2013-11","conditions":"Helicobacter Pylori Infection","enrollment":51},{"nctId":"NCT03003273","phase":"PHASE3","title":"Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study","status":"TERMINATED","sponsor":"All India Institute of Medical Sciences","startDate":"2017-01","conditions":"Neutropenia, Febrile, Pediatric Cancer","enrollment":142},{"nctId":"NCT03802318","phase":"NA","title":"Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-01-02","conditions":"Helicobacter Pylori Infection, Helicobacter Gastritis, Helicobacter-Associated Pyloric Ulcer","enrollment":530},{"nctId":"NCT03021590","phase":"PHASE4","title":"Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori","status":"WITHDRAWN","sponsor":"Damascus Hospital","startDate":"2017-06-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":""},{"nctId":"NCT02486627","phase":"PHASE3","title":"A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Achaogen, Inc.","startDate":"2016-01-11","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":609},{"nctId":"NCT01022567","phase":"NA","title":"Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2009-11","conditions":"Acute Appendicitis","enrollment":530},{"nctId":"NCT03555526","phase":"PHASE4","title":"Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2017-12-15","conditions":"H Pylori Infection","enrollment":320},{"nctId":"NCT02166476","phase":"PHASE3","title":"Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2014-11-20","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":550},{"nctId":"NCT03397680","phase":"PHASE1","title":"Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia","status":"UNKNOWN","sponsor":"Thammasat University","startDate":"2017-05-15","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT03087162","phase":"PHASE4","title":"Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori","status":"COMPLETED","sponsor":"Ramathibodi Hospital","startDate":"2017-01-01","conditions":"H Pylori Eradication","enrollment":180},{"nctId":"NCT01537250","phase":"PHASE2","title":"Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2009-08","conditions":"Community-acquired Pneumonia","enrollment":192},{"nctId":"NCT03391440","phase":"PHASE4","title":"A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease","status":"UNKNOWN","sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","startDate":"2016-09","conditions":"Pelvic Inflammatory Disease","enrollment":469},{"nctId":"NCT02621359","phase":"PHASE3","title":"A Two Week Nitazoxanidebased Quadruple Regimen","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2015-01","conditions":"Dyspepsia","enrollment":100},{"nctId":"NCT02711176","phase":"PHASE4","title":"Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Zahra Vahdat Shariatpanahi","startDate":"2016-09","conditions":"Helicobacter Infection","enrollment":212},{"nctId":"NCT03178292","phase":"NA","title":"Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2017-06-15","conditions":"Percutaneous Nephrolithotomy, Infection, Sepsis","enrollment":300},{"nctId":"NCT03038321","phase":"PHASE4","title":"Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2017-02-01","conditions":"Non-Muscle-invasive Bladder Cancer (NMIBC), Bacillus Calmette-Guerin (BCG) Cystitis, Intra-vesical Instillation","enrollment":150},{"nctId":"NCT03160807","phase":"PHASE4","title":"Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections","status":"UNKNOWN","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-04-15","conditions":"Urinary Tract Infection","enrollment":214},{"nctId":"NCT01725906","phase":"PHASE4","title":"Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-11","conditions":"Self Efficacy","enrollment":450},{"nctId":"NCT03139253","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment","status":"UNKNOWN","sponsor":"Yanqing Li","startDate":"2017-05-30","conditions":"Antimicrobial Susceptibility Testing, Triple Therapy","enrollment":120},{"nctId":"NCT02988089","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2017-04-20","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":480},{"nctId":"NCT02422706","phase":"PHASE3","title":"Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori","status":"UNKNOWN","sponsor":"Sherief Abd-Elsalam","startDate":"2015-01","conditions":"Helicobacter-associated Gastritis","enrollment":120},{"nctId":"NCT01034176","phase":"PHASE4","title":"BK Treatment Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2009-02","conditions":"BK Viremia","enrollment":43},{"nctId":"NCT02693574","phase":"PHASE4","title":"Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori","status":"UNKNOWN","sponsor":"Damascus Hospital","startDate":"2015-12-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":74},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT02596620","phase":"NA","title":"Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2013-10","conditions":"Helicobacter Pylori Infection","enrollment":164},{"nctId":"NCT00362869","phase":"PHASE1","title":"Enteroaggregative E.Coli (EAEC)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-02","conditions":"Escherichia Coli Infections","enrollment":5},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT01618591","phase":"NA","title":"Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea","status":"TERMINATED","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2012-09","conditions":"Acute Watery Diarrhea, Dysentery/Febrile Diarrhea","enrollment":384},{"nctId":"NCT02466919","phase":"PHASE4","title":"Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients","status":"COMPLETED","sponsor":"Chung-Tai Wu","startDate":"2014-05","conditions":"Helicobacter Pylori Infection","enrollment":114},{"nctId":"NCT02884713","phase":"NA","title":"Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia","status":"COMPLETED","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2013-06","conditions":"GASTRITIS","enrollment":55},{"nctId":"NCT02726269","phase":"PHASE3","title":"Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.","status":"COMPLETED","sponsor":"Asofarma de México S.A de C.V.","startDate":"2012-06","conditions":"Helicobacter Pylori Gastritis","enrollment":230},{"nctId":"NCT02712502","phase":"","title":"Levofloxacin in Bacterial Rhinosinussitis","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2014-09","conditions":"Rhinosinusitis","enrollment":100},{"nctId":"NCT02711943","phase":"","title":"Non Interventional Study of Levofloxacin in Chronic Prostatitis","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2013-07","conditions":"Chronic Prostatitis","enrollment":500},{"nctId":"NCT00002850","phase":"PHASE3","title":"Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy","status":"COMPLETED","sponsor":"Gary Morrow","startDate":"1997-03","conditions":"Infection, Multiple Myeloma","enrollment":212},{"nctId":"NCT01875263","phase":"PHASE3","title":"Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.","status":"TERMINATED","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2013-05","conditions":"Staphylococcus","enrollment":1},{"nctId":"NCT00250718","phase":"PHASE2","title":"Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach","status":"TERMINATED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2004-10","conditions":"Non-Hodgkin's Lymphoma, Cancer","enrollment":17},{"nctId":"NCT00431678","phase":"PHASE3","title":"Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-01","conditions":"Pneumonia","enrollment":738},{"nctId":"NCT00665327","phase":"PHASE4","title":"Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-11","conditions":"Pneumonia","enrollment":401},{"nctId":"NCT00683865","phase":"PHASE3","title":"Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-04","conditions":"Pelvic Inflammatory Disease","enrollment":749},{"nctId":"NCT00453349","phase":"PHASE3","title":"A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-01","conditions":"Pelvic Inflammatory Disease","enrollment":460},{"nctId":"NCT01761201","phase":"PHASE3","title":"\"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients\".","status":"TERMINATED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2012-01","conditions":"Latent Tuberculosis Infection, Infection in Solid Organ Transplant Recipients","enrollment":68}],"_emaApprovals":[],"_faersSignals":[{"count":110,"reaction":"ARTHRALGIA"},{"count":89,"reaction":"PAIN IN EXTREMITY"},{"count":62,"reaction":"TENDONITIS"},{"count":56,"reaction":"MYALGIA"},{"count":55,"reaction":"TENDON PAIN"},{"count":50,"reaction":"PAIN"},{"count":49,"reaction":"GAIT DISTURBANCE"},{"count":44,"reaction":"ASTHENIA"},{"count":43,"reaction":"PARAESTHESIA"},{"count":42,"reaction":"MUSCULOSKELETAL PAIN"}],"_approvalHistory":[],"publicationCount":370,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Levolet R"],"phase":"phase_2","status":"active","brandName":"Levofloxacin 500","genericName":"Levofloxacin 500","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and repair. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Complicated urinary tract infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}